Answer
For the Gilead Sciences Ltd elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil product, the pharmaceutical incompatibilities section states “Not applicable.”
Sources for this answer
- Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Gilead150 mg/150 mg/200 mg/245 mg film-coated tabletsGilead Sciences Ltd · emc · SmPC §6.2 Incompatibilities · Version 32Document updated
Sources checked